ResMedMEX:RMD -7.99%99 PEG Ratio is 1.27 as of Jul. 01, 2026, which is 51% below its 10-year median of 2.58. GuruFocus rates MEX:RMD with a GF Score™ of 99/100 and a GF Value™ of MXN4,784.46 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 207 Medical Devices & Instruments companies, ResMed ranks better than 67.15% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, ResMed's PE Ratio without NRI is 17.36. ResMed's 5-Year EBITDA growth rate is 13.70%. Therefore, ResMed's PEG Ratio for today is 1.27.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for ResMed's PEG Ratio or its related term are showing as below:
MEX:RMD'
s PEG Ratio Range Over the Past 10 Years
Min: 1.14 Med: 2.58 Max: 6.1
Current: 1.32
During the past 13 years, ResMed's highest PEG Ratio was 6.10. The lowest was 1.14. And the median was 2.58.
MEX:RMD's PEG Ratio is ranked better than 67.15% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.03
vs MEX:RMD: 1.32
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
ResMed (MEX:RMD) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
ResMed PEG Ratio Related Terms
ResMed PEG Ratio Historical Data
* Premium members only.
The historical data trend for ResMed's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ResMed's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's PEG Ratio distribution charts can be found below:
* The bar in red indicates where ResMed's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
ResMed (MEX:RMD) has a PEG Ratio of 1.27 as of Jul. 01, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on ResMed and its competitors. This is 51% below median its historical median of 2.58. Over the past decade, ResMed's PEG Ratio has ranged from 1.14 to 6.10. According to the industry distribution chart, ResMed ranks #68 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 32.9%.
Is ResMed's PEG Ratio too high?
ResMed's current PEG Ratio of 1.27 is 51% below median its 10-year median of 2.58. Over the past 10 years, this metric has ranged from a low of 1.14 to a high of 6.10. The Medical Devices & Instruments industry median PEG Ratio is 2.03. ResMed's value of 1.27 is 37.4% below this industry median. Based on the distribution chart, ResMed ranks #68 out of 207 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, ResMed has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ResMed's PEG Ratio compare to MDLN and WST?
According to the Medical Devices & Instruments industry distribution chart, ResMed ranks #68 out of 207 companies for PEG Ratio. This puts ResMed in the upper half of its industry. The industry median PEG Ratio is 2.03. ResMed's value of 1.27 is 37.4% below this benchmark. Historically, ResMed's own PEG Ratio has ranged from 1.14 to 6.10 over the past decade. While the company's 10-year median is 2.58 vs. the industry median of 2.03, ResMed has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.03, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ResMed's current PEG Ratio of 1.27 is 37.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on ResMed and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ResMed's current PEG Ratio is 1.27, which is 51% below median its own 10-year median of 2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ResMed stock overvalued right now?
Based on GuruFocus' analysis, ResMed (MEX:RMD) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN4,784.46, compared to a current price of MXN3,419.00 — trading 28.5% below its estimated fair value. The current PEG Ratio is 1.27, which is 51% below median its 10-year median of 2.58 and 37.4% below the Medical Devices & Instruments industry median of 2.03. ResMed's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For ResMed (MEX:RMD), the current PEG Ratio is 1.27 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ResMed (MEX:RMD) Overvalued in 2026?
Based on GuruFocus' analysis, ResMed stock appears to be undervalued.
The current stock price of MXN3,419.00 is trading 28.5% below its estimated GF Value™ of MXN4,784.46.
GuruFocus considers ResMed to be Modestly Undervalued.
Key valuation signals for MEX:RMD:
PEG Ratio: 1.27 (51% below median its 10-year median of 2.58)
GF Value™: MXN4,784.46 vs. price of MXN3,419.00 (28.5% below fair value)
Industry Position: 37.4% below the Medical Devices & Instruments median (#68 of 207)
No single metric tells the full story. See the MEX:RMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
99GF Score
Get the complete analysis for MEX:RMD
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:RMD has been successfully added to your 
